De Regenboog Groep
De Regenboog Groep is a Dutch non-profit providing low-threshold harm reduction services in Amsterdam and hosting the Correlation European Harm Reduction Network (C-EHRN), a network of 100+ organisations across 35+ European countries focused on drug policy and social inclusion.
- Company typePrivate
- Founded2004
- HeadquartersAmsterdam, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingServices
What De Regenboog Groep does
De Regenboog Groep is a Dutch non-governmental foundation (Stichting) established in 1975 and headquartered in Amsterdam. It operates as a community-based organisation providing low-threshold harm reduction, social support, and outreach services to people who use drugs, with attention to Amsterdam's most vulnerable populations, including people involved in the sex industry, those experiencing homelessness, and individuals with co-occurring mental health issues. Its core product beyond direct service delivery is the hosting and coordination of the Correlation European Harm Reduction Network (C-EHRN), established in 2004, which functions as a civil society network spanning more than 35 European countries with over 100 member organisations and 50+ Focal Points.
Through C-EHRN, De Regenboog Groep operates a portfolio of EU-funded projects (including BOOST, EU-COMP, CAPABLE, DRUG-PREP, CORE, SEMID-EU, and ENDCR) and runs a suite of knowledge and training products such as the annual C-EHRN Monitoring Dashboard, the Learn Addiction e-learning platform, the Harm Reduction School, and the ENDCR sub-network platform. Technical components are platform- and content-led rather than software-led: the dashboard aggregates city-level indicators from civil society respondents, the e-learning platform delivers structured curricula to members and external learners, and the ENDCR platform supports a specific community-led response workstream.
The organisation is a non-profit with no commercial revenue model. Services to beneficiaries are provided free of charge, membership in C-EHRN is not a paid subscription, and training resources are accessible to participants. Funding is drawn primarily from EU programme grants (EU4Health, Erasmus+, the EU Justice Programme, Horizon Europe), project-specific grants from the European Commission, and corporate sponsorship, with Gilead explicitly identified as a sponsor. The foundation also holds formal positioning as coordinator of the Civil Society Forum in partnership with EUDA (formerly EMCDDA) and participates in policy fora such as the UN Commission on Narcotic Drugs.
De Regenboog Groep firmographics
Firmographics- Name
- De Regenboog Groep
- Legal name
- Stichting De Regenboog Groep
- Website
- https://correlation-net.org
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- De Regenboog Groep is a Dutch non-profit providing low-threshold harm reduction services in Amsterdam and hosting the Correlation European Harm Reduction Network (C-EHRN), a network of 100+ organisations across 35+ European countries focused on drug policy and social inclusion.
- Ownership category
- akta.pro rank
De Regenboog Groep industry classification
Industry- Product category
- Harm Reduction Services
- NAICS
- Individual and Family Services (6241), Human Rights Organizations (813311), Social Advocacy Organizations (8133)
- SIC
- Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Substance Use, Addiction & Harm Reduction Health Departments (HLAJAAAM)
- akta.pro secondary industry
- Safeguarding, Accountability & Compliance (ESG, Gender/GBV, Do No Harm) (BPADAEAM)
Keywords
Where De Regenboog Groep is headquartered
LocationHeadquarters
- HQ city
- Amsterdam
- HQ country
- Netherlands
- HQ region
- Europe
Offices2 records
Markets served
De Regenboog Groep business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- EU Programme Funding: C-EHRN is co-funded by the European Union and receives grants from EU4Health programme, Erasmus+ Programme, Justice Programme, and other EU funding mechanisms for drug policy initiatives.
- Project Grants: Funding for specific projects including BOOST (EU4Health), EU-COMP (EUDA), CAPABLE (Erasmus+), DRUG-PREP, CORE (EU4Health), and others supporting harm reduction, HIV, hepatitis, and drug policy work.
- Corporate Sponsorship: Financial grants from pharmaceutical companies such as Gilead Science Europe Ltd for specific projects and initiatives.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels9 records
De Regenboog Groep product offering
Product offeringCore offering
De Regenboog Groep is a Dutch non-profit foundation providing low-threshold harm reduction services to people who use drugs and other marginalized communities in Amsterdam. It hosts and coordinates the Correlation – European Harm Reduction Network (C-EHRN), a European civil society network that combines research, advocacy, and practice to drive change across 35+ countries through monitoring, training, capacity building, and policy advocacy on drug use, HIV, hepatitis, and social inclusion.
Product overview
De Regenboog Groep (Foundation Rainbow Group) is a Dutch non-governmental low-threshold service organisation based in Amsterdam, providing harm reduction services to people who use drugs and other marginalised communities. The organisation hosts and coordinates the Correlation – European Harm Reduction Network (C-EHRN), a leading European civil society network combining research, advocacy, and practice in drug policy and harm reduction. The portfolio includes monitoring and data collection services (C-EHRN Monitoring, Civil Society-Led Monitoring), network coordination platforms (ENDCR for drug consumption rooms), e-learning and training resources (Learn Addiction, EU-COMP, CAPABLE), and project-based services addressing communicable diseases (BOOST, CORE), hepatitis C, and prison harm reduction. The organisation serves as a central hub connecting civil society organisations across Europe to drive evidence-based policy and practice improvements.
Differentiator
Problem solved
Functional benefit
Products and services
- C-EHRN Monitoring (Civil Society-Led Monitoring of Harm Reduction in Europe) Annual city-level data collection and reporting on harm reduction service availability, accessibility, quality, continuum of care, equity, system integration, and human rights across European cities, based on input from civil society Focal Points. Used by civil society organizations, policymakers, and researchers to identify gaps, barriers, and inequalities in harm reduction service provision.
- European Network of Drug Consumption Rooms (ENDCR) Membership-based civil society platform uniting organisations operating or planning to implement Drug Consumption Rooms (DCRs) in Europe to enhance availability, accessibility, and quality of these services.
- Learn Addiction E-Learning Platform Comprehensive e-learning platform featuring courses on critical topics such as behavioural dependencies, youth substance use, gender perspective in substance use, and European quality standards in drug use prevention.
- Harm Reduction School Free online platform for professionals providing harm reduction education and training resources.
- Harm Reduction in Prisons Toolkit Toolkit helping civil society organisations provide harm reduction services to incarcerated drug users in Europe, with Module 1 covering access and Module 2 covering good practice examples.
- European Hepatitis C Initiative Initiative launched in 2013 addressing hepatitis C burden among people who use drugs through research, training, capacity building, and advocacy.
Quantifiable outcome
- C-EHRN Monitoring 2025 covers multiple European cities with data on service availability, accessibility, quality, and equity
- +1 more outcomes
Companies that use De Regenboog Groep
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
De Regenboog Groep technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
De Regenboog Groep partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and secondary.
- Gent UniversitycoreAcademic partner in multiple projects including EU-COMP (coordinating consortium), CAPABLE, and FENIQS-EU. Provides research expertise and academic credibility to network activities.
- SCAN/Charles UniversitycorePartner in EU-COMP project consortium for developing training materials for the substance use workforce.
- European Federation of Addiction Societies (EUFAS)corePartner in EU-COMP consortium for competence building materials.
- European Network of People Who Use Drugs (EuroNPUD)corePartner in EU-COMP and other projects, ensuring meaningful involvement of people who use drugs.
- European Union Drugs Agency (EUDA)coreformerly EMCDDA. Coordinates EU-COMP project and collaborates on drug monitoring, policy development, and technical meetings on drug consumption rooms.
- European Forum for Urban Security (EFUS)secondaryCoordinates CAPABLE project on strengthening local responses to youth involvement in drug markets.
- Global Initiative against Transnational Organised Crime (GI-TOC)secondaryPartner in CAPABLE project focusing on youth involvement in drug markets.
- Gaia ParissecondaryPartner in SEMID-EU project on migration and drug use in the EU.
- FixpunktsecondaryPartner in SEMID-EU project addressing needs of migrants who use drugs.
- ISGlobal Barcelona Institute for Global HealthsecondaryPartner in SEMID-EU project on migration and drug use.
- MainlinesecondaryPartner in SEMID-EU project and focal point organization in Amsterdam.
- Trimbos InstitutecorePartner in DRUG-PREP project and focal point in Netherlands. Dutch national institute for mental health and addiction.
- SciensanosecondaryPartner in DRUG-PREP project for drug surveillance and preparedness.
- OKANAsecondaryGreek organization co-organising technical meeting on drug consumption rooms in Athens with ENDCR and EMCDDA.
- ENDCR (European Network of Drug Consumption Rooms)coreMembership-based civil society platform hosted and coordinated by C-EHRN, uniting organisations operating or planning DCRs in Europe.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
De Regenboog Groep competitors and assessment
Company assessmentDirect peers
- Harm Reduction International (HRI): Global civil society network focused on harm reduction policy, advocacy, and the International Harm Reduction Conference. Comparable as a peer-level harm reduction network operating with similar advocacy, monitoring, and capacity-building functions, but at a global rather than European footprint.
- Eurasian Harm Reduction Association (EHRA): Regional harm reduction network for Eastern Europe and Central Asia. Operates a similar civil society network model with member organisations, monitoring, and EU/Global Fund-supported projects covering comparable thematic areas (HIV, HCV, drug policy).
- Aidsfonds: Dutch-based foundation funding community-led HIV, HCV, and harm reduction programmes globally. Comparable as a peer funder and convenor across the same thematic space (community-led harm reduction, HIV/HCV integration) with overlapping partner organisations.
- European AIDS Treatment Group (EATG): Civil society network of people living with HIV and related conditions across Europe. Comparable as a European member-driven network conducting community-led monitoring, advocacy, and capacity-building in overlapping HIV, HCV, and harm reduction domains.
- European Network of People Who Use Drugs (EuroNPUD): European peer-led network of people who use drugs. Direct peer and active C-EHRN project partner (EU-COMP, others), advancing the same harm reduction and human rights agenda with overlapping EU funding sources.
- European Union Drugs Agency (EUDA): EU agency (formerly EMCDDA) providing central drug monitoring and analysis for Europe. Directly comparable as the institutional counterpart to C-EHRN's civil society-led monitoring, and an active co-funding partner on EU-COMP and other projects.
- International Drug Policy Consortium (IDPC): Global network of over 190 NGOs promoting drug policy reform rooted in human rights and public health. Comparable as a similarly structured civil society consortium advocating evidence-based, human-rights-based drug policy at EU and international level.
Broad incumbents
- Frontline AIDS: Global partnership of civil society organisations working on HIV, SRHR, and harm reduction. Comparable as a larger, broader-scope funder and convenor in overlapping thematic areas (harm reduction, key populations, community-led responses).
- World Health Organization (WHO) Regional Office for Europe: UN agency defining global public health policy including on substance use and harm reduction. Comparable as a broader institutional incumbent whose mandates and frameworks shape the environment C-EHRN operates in, with overlapping coverage of the WHO Europe Region.
- United Nations Office on Drugs and Crime (UNODC): UN agency responsible for drug control and crime prevention globally. Comparable as a broader institutional actor shaping international drug policy and attending CND sessions where C-EHRN participates as a civil society voice.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
De Regenboog Groep social profiles
Digital presenceDe Regenboog Groep financial estimates
Financial estimateRevenue estimate
Valuation estimate
De Regenboog Groep leadership team
Management profileNumber of profiles
Profiles1 record
De Regenboog Groep funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
De Regenboog Groep M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about De Regenboog Groep
What does De Regenboog Groep do?
De Regenboog Groep is a Dutch non-profit foundation providing low-threshold harm reduction services to people who use drugs and other marginalized communities in Amsterdam. It hosts and coordinates the Correlation – European Harm Reduction Network (C-EHRN), a European civil society network that combines research, advocacy, and practice to drive change across 35+ countries through monitoring, training, capacity building, and policy advocacy on drug use, HIV, hepatitis, and social inclusion.
Is De Regenboog Groep a public or private company?
De Regenboog Groep is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was De Regenboog Groep founded?
De Regenboog Groep was founded in 2004. It employs 11 to 50 people.
Where is De Regenboog Groep based?
De Regenboog Groep is headquartered in Amsterdam, Netherlands, in the Europe region.
How does De Regenboog Groep make money?
Three revenue lines are on record. EU Programme Funding is the primary driver. The others are project Grants and corporate Sponsorship.
Who are De Regenboog Groep's main competitors?
Direct peers on record are Harm Reduction International (HRI), Eurasian Harm Reduction Association (EHRA), Aidsfonds, European AIDS Treatment Group (EATG), European Network of People Who Use Drugs (EuroNPUD), European Union Drugs Agency (EUDA) and International Drug Policy Consortium (IDPC). Broad incumbents are Frontline AIDS, World Health Organization (WHO) Regional Office for Europe and United Nations Office on Drugs and Crime (UNODC).
Does De Regenboog Groep have an API?
No public API is recorded for De Regenboog Groep.
What industry is De Regenboog Groep in?
De Regenboog Groep's product category is Harm Reduction Services. Its primary akta.pro industry code is HLAJAAAM, Substance Use, Addiction & Harm Reduction Health Departments, with a secondary code of BPADAEAM, Safeguarding, Accountability & Compliance (ESG, Gender/GBV, Do No Harm). Its NAICS code is 6241 and its SIC code is 8300.